The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has updated its recommendations for pneumococcal vaccine in high-risk adults.
GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.
A lot has been happening at Swiss drug maker Novartis in the realm of vaccines.
The Food and Drug Administration has approved a Novartis vaccine for preventing meningococcal disease in children, the Swiss drug maker said.
The Food and Drug Administration has accepted an application from Sanofi Pasteur to expand the...
The Food and Drug Administration has approved a vaccine for preventing pneumococcal disease in children,...